| answer text |
<p>The Veterinary Medicines Directorate is in the process of reviewing the Veterinary
Medicines Regulations 2013 (VMR) to ensure that they are fit for purpose. The powers
to amend and supplement the VMR are set out in the Medicines and Medical Devices Act.</p><p>
</p><p>The Act mandates that, in considering changes to the VMR, we must have regard
to the likelihood of the United Kingdom being seen as a favourable place in which
to develop, manufacture or supply veterinary medicines. Using the powers in the Act
we are able to take a proportionate, risk-based approach to regulation. We intend
to, where possible, reduce administrative burdens on industry, whilst effectively
ensuring safety for animals, humans and the environment, as well as supporting the
availability of veterinary medicines and the UK as an attractive place for UK-based
innovation.</p><p> </p><p>We will carry out a formal public consultation on the proposed
changes to the VMR as they have effect in Great Britain. This consultation will include
an assessment of the impact of those changes on UK businesses and provide the opportunity
for all stakeholders to express their views.</p><p> </p><p> </p>
|
|
